PAUL CORN to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications PAUL CORN has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.534
-
Optimal therapy sequencing in metastatic castration-resistant prostate cancer. Curr Oncol Rep. 2013 Jun; 15(3):217-23.
Score: 0.312
-
Combination of Radiation Therapy and?Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men?With High- and Intermediate-Risk Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 04 01; 109(5):1271-1278.
Score: 0.131
-
Novel therapies for metastatic castrate-resistant prostate cancer. J Natl Cancer Inst. 2011 Nov 16; 103(22):1665-75.
Score: 0.069
-
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer. Cancer. 2015 Jan 01; 121(1):69-76.
Score: 0.021